ESPAX
Price
$39.44
Change
-$1.46 (-3.57%)
Updated
Dec 18 closing price
VSIAX
Price
$85.23
Change
-$3.35 (-3.78%)
Updated
Dec 18 closing price
Ad is loading...

ESPAX vs VSIAX

Header iconESPAX vs VSIAX Comparison
Open Charts ESPAX vs VSIAXBanner chart's image
Allspring Special Small Cap Value A
Price$39.44
Change-$1.46 (-3.57%)
VolumeN/A
CapitalizationN/A
Vanguard Small Cap Value Index Admiral
Price$85.23
Change-$3.35 (-3.78%)
VolumeN/A
CapitalizationN/A
ESPAX vs VSIAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
ESPAX vs. VSIAX commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ESPAX is a Sell and VSIAX is a Hold.

FUNDAMENTALS
Fundamentals
VSIAX has more cash in the bank: 63B vs. ESPAX (5.43B). VSIAX pays higher dividends than ESPAX: VSIAX (2.01) vs ESPAX (0.78). ESPAX was incepted earlier than VSIAX: ESPAX (32 years) vs VSIAX (13 years). ESPAX is a more actively managed with annual turnover of: 22.00 vs. VSIAX (16.00). ESPAX has a lower initial minimum investment than VSIAX: ESPAX (1000) vs VSIAX (3000). VSIAX annual gain was more profitable for investors over the last year : 16.23 vs. ESPAX (4.12). VSIAX return over 5 years is better than : 52.83 vs. ESPAX (18.00).
ESPAXVSIAXESPAX / VSIAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence32 years13 years-
Gain YTD1.99515.03113%
Front LoadN/AN/A-
Min. Initial Investment1000300033%
Min. Initial Investment IRAN/AN/A-
Net Assets5.43B63B9%
Annual Yield % from dividends0.782.0139%
Returns for 1 year4.1216.2325%
Returns for 3 years0.8020.674%
Returns for 5 years18.0052.8334%
Returns for 10 years52.16105.6549%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ALTO1.470.04
+2.80%
Alto Ingredients
ADXN7.80-0.05
-0.64%
Addex Therapeutics Ltd
DCOM33.96-0.84
-2.41%
Dime Community Bancshares
CAVA123.37-3.42
-2.70%
CAVA Group
EWTX30.17-2.52
-7.71%
Edgewise Therapeutics